A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: blood loss (228), haemorrhage (88), flow (235)

Carboplatin-Etoposide

Description
Regimen Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CARBOPLATIN (AUC6)-ETOPOSIDE (Intravenous / Oral) • SCLC – Carboplatin (AUC6)-Etoposide IV/PO Indication • First
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Carboplatin-Etoposide-intravenous-and-oral.pdf

Carboplatin (AUC6) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat Regimen (AUC6) • Ovary – Carboplatin (AUC6) Retreat Indication • Second line or subsequent treatment of platinum sensitive
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC6Retreat.pdf

Carboplatin-Vinorelbine-IV-RT

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN-VINORELBINE-RADIOTHERAPY (Intravenous) Regimen • NSCLC – Carboplatin-Vinorelbine (intravenous)-Radiotherapy Indication • First line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Vinorelbine-IV-RT.pdf

Carboplatin and Vinorelbine (intravenous and oral)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN-VINORELBINE (Intravenous and Oral) Regimen • NSCLC – Carboplatin-Vinorelbine (Intravenous and Oral) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CarboplatinandVinorelbineintravenousandoral.pdf

Pneumatic retionopexy - patient information

Description
Your doctor has recommended that you have a procedure called a pneumaticretinopexy to treat your retinal detachment. We hope this factsheet
Url
/Media/UHS-website-2019/Patientinformation/Eyes/Pneumatic-retionopexy-3432-PIL.pdf

Azathioprine to treat neurological diseases - patient information

Description
This factsheet contains information about the use of azathioprine to treat neurological diseases, including how the treatment is given and the
Url
/Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Azathioprine-to-treat-neurological-diseases-3153-PIL.pdf

CarboplatinAUC5 Etoposide IV/PO

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-ETOPOSIDE (Intravenous / Oral) Regimen • Ovary – Carboplatin (AUC5)-Etoposide IV/PO Indication • Small cell or neuroendocrine
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-EtoposideIVPO.pdf

CarboplatinAUC4-Gemcitabine (1)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1) Regimen • Ovary-Carboplatin (AUC4)-Gemcitabine (1) Indication • Recurrent platinum sensitive ovarian cancer
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabine1.pdf

Carboplatin (AUC5)

Description
Chemotherapy Protocol HEAD AND NECK CANCER CARBOPLATIN (AUC 5) Regimen • Head and Neck – Carboplatin (AUC 5) Indication • Neoadjuvant (in combination with
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Carboplatin-AUC5.pdf

Carboplatin (AUC5)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) Regimen • Ovary – Carboplatin (AUC 5) Indication • Adjuvant treatment in patients with moderate to high risk
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5.pdf
291 to 300 of 705
Previous … 28 29 30 31 32 … Next